FHIR Osiris Implementation Guide
1.1.0 - trial-implementation
This page is part of the OSIRIS FHIR Implementation Guide (v1.1.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Draft as of 2025-04-03 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="AdverseEventGrade"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet AdverseEventGrade</b></p><a name="AdverseEventGrade"> </a><a name="hcAdverseEventGrade"> </a><a name="AdverseEventGrade-en-US"> </a><p>Ce jeu de valeur (ValueSet) inclut les codes selon les règles suivantes :</p><ul><li>Include ces codes sont définis dans <code>https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf</code> version <code>"5.0"</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1</td><td>Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated.</td></tr><tr><td>2</td><td>Moderate; minimal, local or noninvasive intervention indicated; limiting ageappropriate instrumental ADL.</td></tr><tr><td>3</td><td>Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self care ADL</td></tr><tr><td>4</td><td>Life-threatening consequences; urgent intervention indicated.</td></tr><tr><td>5</td><td>Death related to AE.</td></tr></table></li><li>Include ces codes sont définis dans <a href="http://terminology.hl7.org/6.2.0/CodeSystem-umls.html"><code>http://terminology.hl7.org/CodeSystem/umls</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C0439673</td><td>Unknown</td></tr></table></li></ul></div>
</text>
<url
value="https://ig-osiris.cancer.fr/ig/osiris/ValueSet/AdverseEventGrade"/>
<version value="1.1.0"/>
<name value="AdverseEventGrade"/>
<title value="Adverse Event Grade Value Set"/>
<status value="draft"/>
<date value="2025-04-03T15:16:31+02:00"/>
<publisher value="institutcancer"/>
<contact>
<name value="institutcancer"/>
<telecom>
<system value="url"/>
<value value="http://cancer.fr"/>
</telecom>
<telecom>
<system value="email"/>
<value value="osiris@institutcancer.fr"/>
</telecom>
</contact>
<contact>
<name value="Aurélien JOBARD"/>
<telecom>
<system value="email"/>
<value value="osiris@institutcancer.fr"/>
</telecom>
</contact>
<description value="Adverse event grade"/>
<compose>
<include>
<system
value="https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf"/>
<version value=""5.0""/>
<concept>
<code value="1"/>
<display
value="Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated."/>
</concept>
<concept>
<code value="2"/>
<display
value="Moderate; minimal, local or noninvasive intervention indicated; limiting ageappropriate instrumental ADL."/>
</concept>
<concept>
<code value="3"/>
<display
value="Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self care ADL"/>
</concept>
<concept>
<code value="4"/>
<display
value="Life-threatening consequences; urgent intervention indicated."/>
</concept>
<concept>
<code value="5"/>
<display value="Death related to AE."/>
</concept>
</include>
<include>
<system value="http://terminology.hl7.org/CodeSystem/umls"/>
<concept>
<code value="C0439673"/>
<display value="Unknown"/>
</concept>
</include>
</compose>
</ValueSet>